Trading Signals: LGND Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Ligand Pharmaceuticals Inc)
| LGND latest price $101.6800 (-2.39%) ($101.2700 - $105.6000) on Fri. Oct. 9, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.32% (three month average) | RSI | 76 | Latest Price | $101.6800(-2.39%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | LGND advances 0.9% a day on average for past five trading days. | Weekly Trend | LGND advances 5% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Growth stock rally for small cap. | Correlated ETFs | Broad market will support LGND advance at 0% a week (0% probability) IBB(55%) IWO(53%) XBI(51%) IWM(49%) IWC(48%) | Factors Impacting LGND price | LGND will decline at least -1.16% in a week (0% probabilities). VIXM(-21%) UUP(-16%) VXX(-14%) IGOV(-7%) UNG(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.16% (StdDev 2.32%) | Hourly BBV | -2.1 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | 5 Day Moving Average | $102.25(-0.56%) | 10 Day Moving Average | $99.57(2.12%) | 20 Day Moving Average | $96.86(4.98%) | To recent high | -19.8% | To recent low | 13.6% | Market Cap | $1.634b | | | | Ligand Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development and acquisition of technologies that help pharmaceutical companies to discover and develop medicines. Its products include evomela, IV voriconazole, duavee, viviant/conbriza, nexterone, and noxafil-IV. The company was founded by Ronald M. Evans in 1987 and is headquartered in San Diego, CA. |